Why the study?
Blood collection and blood pressure measurements are routinely performed during the same consultation to assess absolute CVD risk, but the effect of blood collection on BP and risk calculation was undetermined.
Does blood collection affect blood pressure measurements and subsequent absolute cardiovascular risk assessment in adults?
Does blood collection affect blood pressure measurements and subsequent absolute cardiovascular risk assessment in adults?
Blood pressure measurements taken at the time of blood collection do not significantly alter the calculation of absolute cardiovascular risk compared to standard clinic measurements.
Answers are grounded in this paper and cite their sources.
Supports using BP at blood collection for CVD risk scoring without altering estimates; leaves open prospective validation.
Background: Blood collection and blood pressure (BP) measurements are routinely performed during the same consultation to assess absolute cardiovascular disease (CVD) risk. This study aimed to determine the effect of blood collection on BP and subsequent calculation of the absolute CVD risk. Methods: Forty-five participants aged 58 ± 9 years (53% male) had systolic BP (SBP) measured using clinical guideline methods (clinic SBP). Then, on a separate visit, BP was measured immediately before, during, and after blood collection. Absolute CVD risk scores were calculated (Framingham equation) using SBP from each measurement condition and compared. Results: The prevalence of low (<10%), moderate (10–15%), and high (≥15%) absolute CVD risks among the participants was 67%, 22%, and 11%, respectively, using clinic SBP. SBP values before and during blood collection were significantly higher compared to values after blood collection (130 ± 18 and 132 ± 19 vs. 126 ± 18 mm Hg; p = 0.010 and p = 0.003, respectively). However, there were no significant differences between clinic SBP (128 ± 18 mm Hg) and blood collection SBP (p = 0.99) or the absolute CVD risk scores (7.3 ± 6.5; 7.6 ± 5.9; 7.7 ± 6.1; and 7.1 ± 5.7%, respectively; p = 0.995 for all). The mean intraclass correlation (95% CI) indicated good agreement between absolute CVD risk scores calculated with clinic SBP and each blood collection SBP (0.86 [95% CI 0.74–0.92], 0.85 [95% CI 0.71–0.91], and 0.87 [95% CI 0.76–0.93], respectively; p < 0.001, for all). Conclusion: Absolute CVD risk calculation is not affected by use of SBP measurements recorded at the time of blood collection. Therefore, it is acceptable to collect blood and measure BP during the same consultation for absolute CVD risk assessment.
No takes yet. Share an insight, caveat, or question.
Chapman et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: